Neurones SA

Neurones SA

35.90
EUR
-1.30
(-3.49%)
1.07BMarket Cap
Mar 10Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
14.44
14.82
16.55
18.43
20.01
20.19
21.01
21.64
23.95
27.47
30.58
33.38
35.27
- -
Basic EPS, GAAP
0.78
0.86
0.89
1.04
1.13
1.07
1.27
1.28
1.56
1.83
2.04
2.17
2.14
- -
Free Cash Flow per Basic Share
0.61
0.97
0.71
0.59
0.59
0.99
2.2
2.48
2.39
1.83
2.23
2.98
2.5
- -
Dividend per Share
0.06
0.06
0.06
0.06
0.06
0.06
0.06
0.2
2
1
1.1
1.2
1.3
- -
Book Value per Share
6.75
7.53
8.19
8.95
10.02
10.99
12.24
13.33
12.86
13.65
14.66
15.58
16.45
15.58
Tangible Book Value per Share
5.22
6
6.54
7.11
8.31
9.32
10.58
11.53
10.97
11.75
12.4
13.18
13.87
13.18
Basic Weighted Avg Shares
24
24
24
24
24
24
24
24
24
24
24
24
24
24
Sales/Revenue/Turnover
343
355
399
447
485
490
510
524
580
665
741
810
857
- -
Operating Margin (%)
9.53
10.01
9.18
9.45
9.13
9.27
9.55
9.73
10.62
10.81
10.12
9.63
8.84
- -
Depreciation Expense
5
5
6
7
8
8
15
16
15
17
17
18
20
- -
Net Income, GAAP
19
21
21
25
27
26
31
31
38
44
49
53
52
- -
Effective Tax Rate (%)
38.45
36.63
36.27
35.43
33.84
37.8
34.67
34.68
30.47
28.95
27.47
28.24
27.29
- -
Profit Margin (%)
5.41
5.77
5.35
5.64
5.63
5.3
6.04
5.89
6.5
6.65
6.67
6.49
6.07
- -
Working Capital
126
147
151
173
204
232
256
288
280
299
317
335
358
335
LT Debt
- -
- -
2
1
- -
- -
25
27
28
27
31
29
26
29
Total Equity
175
197
216
238
268
296
327
359
353
376
410
436
465
436
Return on Invested Capital (%)
8.63
8.71
8.28
8.7
8.59
7.65
8.36
7.23
8.76
10.19
10.01
9.52
8.98
- -
Return on Capital (%)
9.56
9.39
8.82
9.38
9.08
8.02
8.34
7.32
8.48
9.49
9.55
9.27
8.89
- -
Return on Common Equity (%)
12.14
11.98
11.27
12.13
11.87
10.18
10.92
9.98
11.89
13.78
14.4
14.32
13.38
- -

Capital Structure

EUR

•

in mil. unless spec.
Dec'23
Jun'24
Dec'24
ST Debt
13
17
13
LT Borrowings
2
2
2
LT Finance Leases
29
28
27
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
24
24
24
Market Capitalization
1,062
979
1,067

Working Capital

EUR

•

in mil. unless spec.
Dec'23
Jun'24
Dec'24
Total Current Assets
546
546
588
Cash, Cash Equivalents & STI
298
268
326
Accounts Receivable, Net
174
176
172
Inventories
1
2
- -
Total Current Liabilities
229
243
253
Payables & Accruals
- -
- -
- -
ST Debt
13
17
13
Deferred Revenue
- -
- -
- -

Growth Rates

EUR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
8.05%
5.37%
6.58%
Free Cash Flow
19.85%
2.55%
-15.9%
Net Income, GAAP
9.69%
11.28%
-0.92%
Sales/Revenue/Turnover
8.02%
10.36%
5.78%
Total Cash Common Dividend
- -
175.59%
8.58%

Semi-annual Revenue

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
741
2024
- -
- -
810
2025
- -
- -
857

Semi-annual Earnings Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
2.04
2024
- -
- -
2.17
2025
- -
- -
2.14

Semi-annual Dividends Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
1.1
2024
- -
- -
1.2
2025
- -
- -
1.3

Company Description

CEO
Luc de Chammard
Full Time Employees
7,208
Sector
Commercial services
Industry
Miscellaneous commercial services
Address
Immeuble “le Clemenceau 1” Nanterre IF France 92024
IPO Date
May 23, 2000
Business
Neurones S.A. provides consulting and information technology services, specializing in infrastructure management, application development, and digital transformation solutions. Founded in 1984 and headquartered in Nanterre, France, the company operates primarily in France with over 7,000 employees across three main business segments: infrastructure services encompassing cloud computing, DevOps, cybersecurity, user support, IT service management, information system governance, and automation; application services including digital technologies, UX/UI design, agile methodologies, mobility solutions, data analytics, SAP integration, outsourcing, content management, business process management, and paperless processes; and consulting services covering strategy, management, organization, digital marketing, human resources transformation, big data, artificial intelligence, blockchain, and innovation with connected devices. Neurones S.A. serves diverse sectors such as banking and insurance, services and consumer goods, energy and utilities, healthcare, technology, media and telecoms, industry, construction, civil engineering, and the public sector. In fiscal year 2024, Neurones S.A. achieved 8.6% organic growth and a 7.8% increase in net profit, followed by continued expansion with 3.9% organic growth in the first quarter of 2025, 5.3% in the second quarter, and 5.1% in the third quarter, alongside a 6.3% net profit margin in the first half of 2025; the company also made its 2024 Universal Registration Document available and manages an active share buyback program, holding over 10,000 treasury shares as of October 2025.

Company News

  • NEURONES: Organic growth up 8% in 2nd quarter 2026

  • NEURONES : + 8 % de croissance organique au 2e trimestre 2026

  • NEURONES: Declaration of transactions on treasury shares (April 13 to 17, 2026)

  • NEURONES : Déclaration des transactions sur actions propres (période du 13 au 17 avril 2026)

  • NEURONES: Declaration of transactions on treasury shares (March 30 to April 3, 2026)

  • NEURONES :

  • NEURONES: Net profit, Group share stable in 2025

  • NEURONES : Résultat net part du groupe stable en 2025